Result of EGM

Azure Holdings PLC 02 October 2006 Azure Holdings plc Result of EGM On 11 September 2006, Azure Holdings plc ('Azure' or the 'Company') announced that it had agreed, subject, inter alia, to Shareholder approval, to acquire the entire issued share capital of ValiRx Limited, a biopharmaceutical development company that is looking to exploit opportunities in the healthcare, life sciences and biopharmaceutical industries. At the Extraordinary General Meeting and Class Meetings of Azure, which took place earlier today, all resolutions put to Shareholders to effect the Capital Reorganisation and Acquisition were duly approved. It is expected that Admission will become effective and that dealings in the new ordinary shares of 0.2p each will commence on AIM on 3 October 2006. The change of name to ValiRx plc is now expected to be effective from 4 October 2006. All terms used in this announcement are defined as set out in the admission document dated 8 September 2006. For further information: Gerry Desler, Azure Holdings plc Tel: 01277 366 558 David Youngman, WH Ireland Limited Tel: 0161 832 2174 This information is provided by RNS The company news service from the London Stock Exchange

Companies

Valirx (VAL)
UK 100